Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention - PubMed (original) (raw)
Review
Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention
R Austrian. Rev Infect Dis. 1981 Mar-Apr.
Abstract
Although the means whereby pneumococcus damages the hosts it invades remain unknown, some advances in understanding the biology of this organism and the pathogenesis of pneumococcal infection have been made in recent years. Knowledge of the composition of the cell wall (C) polysaccharide of the pneumococcus and its relation to the capsular polysaccharides of this organism is considered and a hypothesis of the evolution of the pneumococcal capsule is entertained. Refinements in understanding the pathogenesis of pneumococcal pneumonia, bacteremia, and otitis media are reviewed, and current knowledge of the epidemiology of pneumococcal infections and of the distribution of pneumococcal types causing such infections is discussed. The history of the development of pneumococcal vaccines is summarized briefly, together with an account of the field trials of contemporary polyvalent vaccines of pneumococcal capsular polysaccharides conducted recently.
Similar articles
- New vaccines for the prevention of pneumococcal infections.
Käyhty H, Eskola J. Käyhty H, et al. Emerg Infect Dis. 1996 Oct-Dec;2(4):289-98. doi: 10.3201/eid0204.960404. Emerg Infect Dis. 1996. PMID: 8969245 Free PMC article. Review. - Pneumococcal otitis media and pneumococcal vaccines, a historical perspective.
Austrian R. Austrian R. Vaccine. 2000 Dec 8;19 Suppl 1:S71-7. doi: 10.1016/s0264-410x(00)00282-6. Vaccine. 2000. PMID: 11163467 - Clinical studies of pneumococcal vaccines in infants. II. Efficacy and effect on nasopharyngeal carriage.
Wright PF, Sell SH, Vaughn WK, Andrews C, McConnell KB, Schiffman G. Wright PF, et al. Rev Infect Dis. 1981 Mar-Apr;3 Suppl:S108-12. doi: 10.1093/clinids/3.supplement_1.s108. Rev Infect Dis. 1981. PMID: 7280442 - Novel vaccine strategies with protein antigens of Streptococcus pneumoniae.
Swiatlo E, Ware D. Swiatlo E, et al. FEMS Immunol Med Microbiol. 2003 Aug 18;38(1):1-7. doi: 10.1016/S0928-8244(03)00146-9. FEMS Immunol Med Microbiol. 2003. PMID: 12900048 Review.
Cited by
- Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination.
Westerink MA, Schroeder HW Jr, Nahm MH. Westerink MA, et al. Aging Dis. 2012 Feb;3(1):51-67. Epub 2011 Jul 20. Aging Dis. 2012. PMID: 22500271 Free PMC article. - Population structure of invasive Streptococcus pneumoniae in The Netherlands in the pre-vaccination era assessed by MLVA and capsular sequence typing.
Elberse KE, van de Pol I, Witteveen S, van der Heide HG, Schot CS, van Dijk A, van der Ende A, Schouls LM. Elberse KE, et al. PLoS One. 2011;6(5):e20390. doi: 10.1371/journal.pone.0020390. Epub 2011 May 26. PLoS One. 2011. PMID: 21637810 Free PMC article. - Synthesis of a conjugate vaccine composed of pneumococcus type 14 capsular polysaccharide bound to pertussis toxin.
Schneerson R, Levi L, Robbins JB, Bryla DM, Schiffman G, Lagergard T. Schneerson R, et al. Infect Immun. 1992 Sep;60(9):3528-32. doi: 10.1128/iai.60.9.3528-3532.1992. Infect Immun. 1992. PMID: 1500160 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical